ÂÜÀòÂÒÂ×

Alan K. Hauser is a PrecisionCare executive championing life-sciences Innovation-to-Commercialization (I2C) by translating the promise of emerging proprietary multi-omic platforms into practice. Dr. Hauser has over three decades of experience in technical, intellectual, property, market, and business development aspects of commercializing drug-discovery and diagnostics inventions.

Dr. Hauser co-invented four U.S. patents covering microfluidic bio tools and launched nine drug-discovery and DNA diagnostic products. This resulted in two initial public offerings that include a Silicon Valley lab-on-a-chip venture of $180 million IPO. Five of these companies have acquired totaling over $1.8 billion. Dr. Hauser led an I2C team that focused on biomarker-enabled companion diagnostics acquiring $150 million of IP-powered revenue per year. His experience in stratified medicine is particularly relevant to the mission of FlowCell and Fluids for Life.